← Back to Search

Behavioral Intervention

3D printed model for Maternal-Fetal Relationship

N/A
Waitlist Available
Led By John Cote, MD
Research Sponsored by Creighton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age - Female 19-45 years of age
Fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

This study is evaluating whether a 3D model of a fetus' face will help mothers quit smoking.

Eligible Conditions
  • Maternal-Fetal Relationship
  • Maternal Behavior

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maternal Antenatal Attachment Scale (MAAS)
Salivary cotinine
The Timeline Follow Back (TLFB)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 3D printed modelExperimental Treatment1 Intervention
Mother is given 3D printed model of fetus' face
Group II: PlaceboPlacebo Group1 Intervention
Mother is given printed picture of 3D ultrasound of fetus
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
3D printed model
2018
N/A
~470

Find a Location

Who is running the clinical trial?

Creighton UniversityLead Sponsor
125 Previous Clinical Trials
25,600 Total Patients Enrolled
John Cote, MDPrincipal InvestigatorCreighton University
1 Previous Clinical Trials
288 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~26 spots leftby Mar 2025